MedPath
HSA Approval

GARASENT INJECTION 80 mg/2 ml

SIN11085P

GARASENT INJECTION 80 mg/2 ml

GARASENT INJECTION 80 mg/2 ml

August 27, 1999

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01GB03

gentamicin

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA (M) SDN BHD

Active Ingredients

GENTAMICIN SULPHATE EQV GENTAMICIN

80 mg/2 ml

Gentamicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GARASENT INJECTION 80 mg/2 ml - HSA Approval | MedPath